The portfolio contains a diverse range of formulations including of oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids such as cannabidiol (“CBD”), cannabigerol (“CBG”), and tetrahydrocannabinol (“THC”).

The formulary is supported by ongoing consumer, patient, and medical community education and training including https://www.avicanna.com/avicenna-academy. 

The brand is currently available nationwide to patients in medical channels across Canada including a strategic partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart Inc.™, RHO Phyto is also accessible through several other medical portals such as The University Health Network (“UHN”) and the Odette Cancer Centre pharmacy of Sunnybrook Health Science Centre, a major hospital group in Canada. The products are also available in adult-use sales channels through provincial retailers in four provinces including Ontario, British Columbia, New Brunswick, Manitoba, and Saskatchewan.